Social scientist and technology expert Zeynep Tufekci has been prescient about COVID-19 transmission. Eric Topol talks with her about how she does it and why such approaches make the difference.

Six researchers offer tips for navigating through and beyond gender barriers.

An interview with the directors of PsyArxiv, SocArxiv, and Marxiv.

Representative Bill Foster weighs in on the most important science issues facing the country.

"It's hard to see yourself in a career where you don't see other people who are like you."

Only about 5% of the institutions made explicit mention of open access in their guidelines, and, in several of those few cases, the mention was done to call attention to the potentially problematic nature of these journals.

In an era when untestable ideas such as the multiverse hold sway, Michela Massimi defends science from those who think it hopelessly unmoored from physical reality.

Catherine Winchester was hired to ferret out errors and establish routines that promote rigorous research.

The Swiss universities are negotiating with the world’s three largest scientific publishers for fair – in other words affordable – terms of access. Michael Hengartner, president of swissuniversities and UZH, explains the background.

A researcher explains how - and why - he spent a whole summer harvesting information from the platform, which is notoriously hard to mine.

"If you [only] have products created by white guys in their 20s, you’re gonna miss the mark."

Lutz Jäncke and Lawrence Rajendran talk about the crisis in the publication process and new solutions.

An interview presents the perspectives of Jonathan Tennant, an early-career researcher.

Using a database of 750 cases of research fraud from around the world, professors examine fraud as a phenomenon, tracing its history and trajectory and looking at what can be done about it.

Biologists' positive personal experiences with preprints.

We talk to Dr Richard Bowman about designing 3D-printable microscopes.

EMBL-EBI’s open chemistry data services combine curiosity-driven science and pragmatic solution-finding for drug discovery.